Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666237 · ClinicalTrials.gov registry record · Phase 4
Primary Tube Versus Trabeculectomy Study
A Phase 4 study of Glaucoma, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 242
- Enrollment target
- 16
- Study locations
NCT00666237 is a Phase 4 study of Glaucoma that has completed, run by University of Miami. The registered enrollment target is 242 participants, below the 908-participant average among 92 other Glaucoma trials with a reported enrollment target (73% lower). The trial reports 16 study locations across 11 states.
The verdict
NCT00666237, a Phase 4 study of Glaucoma, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 242 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of the Primary Tube Versus Trabeculectomy (PTVT) Study is to compare the long-term safety and efficacy of nonvalved tube shunt surgery to trabeculectomy with mitomycin C in eyes that have not had previous ocular surgery.
Conditions Studied
Interventions
- DRUG Mitomycin C
- PROCEDURE Tube shunt surgery
- PROCEDURE Trabeculectomy
Study Locations (16)
Other
- University of Toronto - Toronto
- Moorfields Eye Hospital - London
- St. Thomas' Hospital - London
- Queen Mary's Sidcup Hospital - Sidcup
Florida
- University of Florida - Gainesville
- Bascom Palmer Eye Institute - Miami
Texas
- Glaucoma Associates of Texas - Dallas
- University of Texas, Houston - Houston
California
- University of California Davis Medical Center - Sacramento
Maryland
- Johns Hopkins - Baltimore
Missouri
- St. Louis University - St Louis
New York
- New York Eye and Ear Infirmary - New York
Ohio
- Cincinnati Eye Institute - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2008-04-01 |
| Est. Completion | 2021-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00666237
The ClinicalTrials.gov registry entry for NCT00666237 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 908-participant average among 92 other Glaucoma trials with a reported enrollment target (73% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 3 interventions - of which Mitomycin C is the first listed.
NCT00666237 reports 16 study locations spanning 11 distinct geographic areas - top geographies include Other, Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT00666237 about?
NCT00666237 is a clinical study titled "Primary Tube Versus Trabeculectomy Study". The purpose of the Primary Tube Versus Trabeculectomy (PTVT) Study is to compare the long-term safety and efficacy of nonvalved tube shunt surgery to trabeculectomy with mitomycin C in eyes that have not had previous ocular surgery.
What is the current status of trial NCT00666237?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 242 participants. The study started on 2008-04-01. Estimated completion is 2021-04-01.
What conditions does trial NCT00666237 study?
This clinical trial studies the following conditions: Glaucoma.
What interventions are being tested in trial NCT00666237?
The interventions under investigation include: Mitomycin C (DRUG), Tube shunt surgery (PROCEDURE), Trabeculectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00666237?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00666237 being conducted?
This trial has 16 study locations across California, Florida, Maryland, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Retinal Blood Flow and Autoregulation
RECRUITING · Phase 4
-
Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
RECRUITING · Phase 4
-
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
RECRUITING · Phase 4
-
Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
COMPLETED · Phase 4
-
Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
COMPLETED · Phase 4
-
Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.